Zacks Research Expects Reduced Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Zacks Research dropped their Q3 2024 EPS estimates for DENTSPLY SIRONA in a report released on Monday, October 21st. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of $0.47 per share for the quarter, down from their previous forecast of $0.48. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.98 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s FY2024 earnings at $1.96 EPS, FY2025 earnings at $2.26 EPS, Q3 2026 earnings at $0.61 EPS and FY2026 earnings at $2.50 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The business’s quarterly revenue was down 4.3% compared to the same quarter last year.

Several other equities analysts have also commented on XRAY. Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Stifel Nicolaus lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Finally, Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and an average target price of $33.22.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $24.28 on Tuesday. The firm’s fifty day moving average price is $25.30 and its 200-day moving average price is $26.61. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The stock has a market cap of $4.92 billion, a P/E ratio of -28.23, a price-to-earnings-growth ratio of 1.19 and a beta of 1.00. DENTSPLY SIRONA has a fifty-two week low of $23.58 and a fifty-two week high of $37.60.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were given a $0.16 dividend. The ex-dividend date was Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.64%. DENTSPLY SIRONA’s payout ratio is currently -74.42%.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently modified their holdings of the company. Raymond James Trust N.A. increased its position in DENTSPLY SIRONA by 4.9% during the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after acquiring an additional 453 shares during the last quarter. LRI Investments LLC increased its position in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Diversified Trust Co increased its position in DENTSPLY SIRONA by 3.0% during the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after acquiring an additional 566 shares during the last quarter. Epoch Investment Partners Inc. grew its holdings in shares of DENTSPLY SIRONA by 2.2% in the second quarter. Epoch Investment Partners Inc. now owns 30,169 shares of the medical instruments supplier’s stock worth $752,000 after purchasing an additional 647 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in shares of DENTSPLY SIRONA by 6.6% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier’s stock worth $357,000 after purchasing an additional 662 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.